Johnson & Johnson Levoreact, Levoreact 0.5 mg 10 ml Johnson & Johnson

“Composition
One ml of nasal spray, suspension contains: levocabastine hydrochloride 0.54 mg (equivalent to 0.5 mg of levocabastine). Excipients: propylene glycol, sodium phosphate monohydrate, disodium phosphate anhydrous, hydroxypropyl methylcellulose, polysorbate 80, benzalkonium chloride, disodium edetate, purified water.
Excipients
Propylene glycol, sodium phosphate monohydrate, disodium phosphate anhydrous, hydroxypropyl methylcellulose, polysorbate 80, benzalkonium chloride, disodium edetate, purified water.
Therapeutic indications
Symptomatic treatment of allergic rhinitis

Contraindications
Hypersensitivity to the active substance or to any of the excipients. Generally contraindicated during pregnancy (see 4.6).

Dosage
Since the nasal spray, LEVOREACT suspension is available as a microsuspension, the bottle should be shaken before each use. Adults and children over 3 years old: the usual dose is 2 sprays in each nostril 2 times a day. If necessary, the dose can be repeated up to 3-4 times a day. Treatment should be continued for as long as necessary for symptoms to disappear. The patient should be instructed to blow his nose well before using LEVOREACT nasal spray, suspension. Before the first use of the drug, remove the cap and press two or three times until a regular dose is obtained.

Warnings and precautions
Since levocabastine is excreted primarily by the kidneys, LEVOREACT nasal spray suspension should be administered with caution to patients with renal insufficiency. Like all nasal preparations containing benzalkonium chloride, propylene glycol and esters, Levoreact may cause skin irritation.”